1. Home
  2. BHVN
  3. BHVN News

Latest Biohaven Ltd. (BHVN) News on May 9, 2025

Why BioHaven Stock Is Soaring Today
BHVN

Motley Fool

11 days ago

Why BioHaven Stock Is Soaring Today

Biohaven Announces Investment up to $600 Million by Oberland Capital
BHVN

PR Newswire

11 days ago

Biohaven Announces Investment up to $600 Million by Oberland Capital

Biohaven share price undervaluing pipeline potential, says RBC Capital
BHVN

TipRanks

13 days ago

Biohaven share price undervaluing pipeline potential, says RBC Capital

Why Biohaven Stock Plummeted by More Than 15% Today
BHVN

Motley Fool

13 days ago

Why Biohaven Stock Plummeted by More Than 15% Today

Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21
BHVN

Insider Monkey

15 days ago

Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21

Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
BHVN

Insider Monkey

16 days ago

Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts?

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting
BHVN

PR Newswire

a month ago

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
BHVN

Motley Fool

a month ago

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

American Century Companies boosts stake in Biohaven, ETF Daily News says
BHVN

TipRanks

a month ago

American Century Companies boosts stake in Biohaven, ETF Daily News says

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
BHVN

GlobeNewswire

a month ago

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025
BHVN

Insider Monkey

2 months ago

Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025

Biohaven price target lowered to $63 from $69 at Morgan Stanley
BHVN

TipRanks

2 months ago

Biohaven price target lowered to $63 from $69 at Morgan Stanley

Estimating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
BHVN

Simply Wall St.

2 months ago

Estimating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
BHVN

Investor's Business Daily

2 months ago

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

Company News for Mar 4, 2025
BHVN

Zacks

2 months ago

Company News for Mar 4, 2025

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
BHVN

PR Newswire

2 months ago

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300

Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results
BHVN

PR Newswire

2 months ago

Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results

Why Biohaven Stock Triumphed on Tuesday
BHVN

Motley Fool

3 months ago

Why Biohaven Stock Triumphed on Tuesday

Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
BHVN

Investor's Business Daily

3 months ago

Biohaven Just Hurdled An FDA Setback — And Its Moving Lines

Why Biohaven (BHVN) Stock Is Rallying Today
BHVN

Insider Monkey

3 months ago

Why Biohaven (BHVN) Stock Is Rallying Today

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia
BHVN

PR Newswire

3 months ago

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia

Pfizer to Pay $60 Million in Kickback, False Claims Settlement
BHVN

The Wall Street Journal

3 months ago

Pfizer to Pay $60 Million in Kickback, False Claims Settlement

Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy
BHVN

PR Newswire

4 months ago

Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
BHVN

GlobeNewswire

4 months ago

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs

Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BHVN

PR Newswire

4 months ago

Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Insider Buying: Biohaven Independent Director Bought US$1.0m Of Shares
BHVN

Simply Wall St.

4 months ago

Insider Buying: Biohaven Independent Director Bought US$1.0m Of Shares

Company News for Jan 2, 2025
BHVN

Zacks

4 months ago

Company News for Jan 2, 2025

Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval
BHVN

Benzinga

5 months ago

Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval

Is Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
BHVN

Insider Monkey

5 months ago

Is Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates
BHVN

PR Newswire

5 months ago

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates

Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting
BHVN

PR Newswire

5 months ago

Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting

Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study
BHVN

Benzinga

5 months ago

Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study

Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity
BHVN

PR Newswire

5 months ago

Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments
BHVN

PR Newswire

6 months ago

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments

Scholar Rock Jumps 362% On Final-Phase Win In Spinal Muscular Atrophy
BHVN

Investor's Business Daily

7 months ago

Scholar Rock Jumps 362% On Final-Phase Win In Spinal Muscular Atrophy

Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy
BHVN

Investor's Business Daily

7 months ago

Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy

BHVN

MT Newswires

7 months ago

Biohaven Ltd Insider Bought Shares Worth $999,970, According to a Recent SEC Filing

Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock
BHVN

Simply Wall St.

7 months ago

Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
BHVN

PR Newswire

7 months ago

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Biohaven Announces Pricing of $250 Million Public Offering of Common Shares
BHVN

PR Newswire

7 months ago

Biohaven Announces Pricing of $250 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares
BHVN

PR Newswire

7 months ago

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
BHVN

PR Newswire

7 months ago

Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
BHVN

Zacks

7 months ago

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More

BHVN

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 09/26/2024

BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal
BHVN

Zacks

7 months ago

BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal

Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
BHVN

PR Newswire

8 months ago

Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)

Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia
BHVN

PR Newswire

8 months ago

Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia

Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In?
BHVN

Insider Monkey

9 months ago

Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In?

Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
BHVN

PR Newswire

9 months ago

Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
BHVN

GlobeNewswire

a year ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series
BHVN

PR Newswire

a year ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029
BHVN

GlobeNewswire

a year ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights
BHVN

GlobeNewswire

a year ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results
BHVN

Insider Monkey

a year ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options
BHVN

GlobeNewswire

a year ago

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

"Green Energy" Brings Charging Piles to Mountain Villages
BHVN

PR Newswire

a year ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032
BHVN

GlobeNewswire

a year ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day
BHVN

PR Newswire

a year ago

Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors
BHVN

PR Newswire

a year ago

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors

BHVN

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 05/16/2024

Director Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN)
BHVN

GuruFocus.com

a year ago

Director Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN)

Down -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround
BHVN

Zacks

a year ago

Down -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround

Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround
BHVN

Zacks

a year ago

Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround

Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
BHVN

PR Newswire

a year ago

Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments

Independent Director of Biohaven John Childs Buys 3.2% More Shares
BHVN

Simply Wall St.

a year ago

Independent Director of Biohaven John Childs Buys 3.2% More Shares

BHVN

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 04/26/2024

Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)
BHVN

GuruFocus.com

a year ago

Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)

Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)
BHVN

GuruFocus.com

a year ago

Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares
BHVN

PR Newswire

a year ago

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates
BHVN

PR Newswire

a year ago

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates

LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?
BHVN

TipRanks

a year ago

LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?

Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock
BHVN

Simply Wall St.

a year ago

Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock

Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
BHVN

PR Newswire

a year ago

Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments

A Look At The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
BHVN

Simply Wall St.

a year ago

A Look At The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)

Will PBF Energy (PBF) Beat Estimates Again in Its Next Earnings Report?
BHVN

Zacks

a year ago

Will PBF Energy (PBF) Beat Estimates Again in Its Next Earnings Report?

Post Holdings Inc (POST) Reports Strong Q1 Fiscal 2024 Results, Raises Full-Year Guidance
BHVN

GuruFocus.com

a year ago

Post Holdings Inc (POST) Reports Strong Q1 Fiscal 2024 Results, Raises Full-Year Guidance

Everhome Suites Continues Sustained Growth Across the Southwest with Six Groundbreakings
BHVN

PR Newswire

a year ago

Everhome Suites Continues Sustained Growth Across the Southwest with Six Groundbreakings

Accenture (ACN) is a Top-Ranked Growth Stock: Should You Buy?
BHVN

Zacks

a year ago

Accenture (ACN) is a Top-Ranked Growth Stock: Should You Buy?

Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
BHVN

InvestorPlace

a year ago

Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs

General Electric Company (NYSE:GE) Q4 2023 Earnings Call Transcript
BHVN

Insider Monkey

a year ago

General Electric Company (NYSE:GE) Q4 2023 Earnings Call Transcript

BHVN

Associated Press Finance

a year ago

Popular: Q4 Earnings Snapshot

Popular, Inc. Announces Fourth Quarter 2023 Financial Results
BHVN

Business Wire

a year ago

Popular, Inc. Announces Fourth Quarter 2023 Financial Results

Here's Why You Should Hold Ingersoll Rand (IR) in Your Portfolio
BHVN

Zacks

a year ago

Here's Why You Should Hold Ingersoll Rand (IR) in Your Portfolio

BHVN

Thomson Reuters StreetEvents

a year ago

Q4 2023 Old National Bancorp Earnings Call

Old National Bancorp (ONB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
BHVN

Zacks

a year ago

Old National Bancorp (ONB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Instacart to Report Fourth Quarter and Full Year 2023 Financial Results on February 13, 2024
BHVN

PR Newswire

a year ago

Instacart to Report Fourth Quarter and Full Year 2023 Financial Results on February 13, 2024

12 S&P 500 Stocks On the Move
BHVN

Insider Monkey

a year ago

12 S&P 500 Stocks On the Move

Obesity Drugs Lead to Muscle Loss—Pharma Companies Want to Fix That
BHVN

The Wall Street Journal

a year ago

Obesity Drugs Lead to Muscle Loss—Pharma Companies Want to Fix That

There Are Reasons To Feel Uneasy About Chart Industries' (NYSE:GTLS) Returns On Capital
BHVN

Simply Wall St.

a year ago

There Are Reasons To Feel Uneasy About Chart Industries' (NYSE:GTLS) Returns On Capital

5 High ROE Stocks to Buy as Markets Dip on Inflation Worry
BHVN

Zacks

a year ago

5 High ROE Stocks to Buy as Markets Dip on Inflation Worry

Q3 Earnings Review: Data Infrastructure Stocks Led by Teradata (NYSE:TDC)
BHVN

StockStory

a year ago

Q3 Earnings Review: Data Infrastructure Stocks Led by Teradata (NYSE:TDC)

Antero Midstream Announces Pricing of Upsized $600 Million Offering of Senior Notes
BHVN

PR Newswire

a year ago

Antero Midstream Announces Pricing of Upsized $600 Million Offering of Senior Notes

Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology
BHVN

PR Newswire

a year ago

Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology

Insmed Inc Chief Commercial Officer John Wise Sells 21,238 Shares
BHVN

GuruFocus.com

a year ago

Insmed Inc Chief Commercial Officer John Wise Sells 21,238 Shares

5 Great REITs To Buy In 2024
BHVN

Benzinga

a year ago

5 Great REITs To Buy In 2024

Concentrix Schedules Release of Fourth Quarter and Full Year Fiscal 2023 Financial Results and Webcast of Investor Conference Call
BHVN

GlobeNewswire

a year ago

Concentrix Schedules Release of Fourth Quarter and Full Year Fiscal 2023 Financial Results and Webcast of Investor Conference Call

Dillard's (DDS) Customer Base & Fashion Foresight Fuel Growth
BHVN

Zacks

a year ago

Dillard's (DDS) Customer Base & Fashion Foresight Fuel Growth

Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BHVN

PR Newswire

a year ago

Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Share on Social Networks: